Skip to main content
. 2014 Apr 29;38(3):173–179. doi: 10.1016/j.jgr.2014.04.003

Fig. 3.

Fig. 3

Antiviral activity of ginsenosides against HRV3 in HeLa cells. HeLa cells were infected with HRV3, after which they were treated with the indicated concentrations of ginsenosides for 48 h. Antiviral activity was assessed using a Cell Titer-Glo Luminescent cell viability assay. Data are presented as mean ± SD from three independent experiments each carried out in triplicate. HRV3, human rhinovirus 3.